SKIN (SkinHealth Systems) ROCE %: -0.59% (As of Mar. 2026)


SKIN SkinHealth Systems Inc SKIN
49 GF Score
Price $0.66
GF Value $1.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is SkinHealth Systems ROCE %?

SkinHealth Systems SKIN +3.17% 49 ROCE % is -0.59% as of Mar. 2026. GuruFocus rates SKIN with a GF Score™ of 49/100 and a GF Value™ of $1.50 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SkinHealth Systems's annualized ROCE % for the quarter that ended in Mar. 2026 was -0.59%.

SkinHealth Systems  (NAS:SKIN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SkinHealth Systems ROCE % Related Terms

SkinHealth Systems ROCE % Historical Data

* Premium members only.

The historical data trend for SkinHealth Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SkinHealth Systems ROCE % Chart

SkinHealth Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -55.29 5.66 -10.11 -2.67 2.88

SkinHealth Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.37 17.27 -3.90 1.66 -0.59
SKIN
49GF Score
SkinHealth Systems Inc SKIN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SkinHealth Systems ROCE % Calculation

SkinHealth Systems's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=13.388/( ( (685.683 - 68.152) + (499.803 - 186.275) )/ 2 )
=13.388/( (617.531+313.528)/ 2 )
=13.388/465.5295
=2.88 %

SkinHealth Systems's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1.872/( ( (499.803 - 186.275) + (473.233 - 155.202) )/ 2 )
=-1.872/( ( 313.528 + 318.031 )/ 2 )
=-1.872/315.7795
=-0.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.59% mean?
SkinHealth Systems (SKIN) has a ROCE % of -0.59% as of Mar. 2026.
Is SkinHealth Systems' ROCE % too high?
SkinHealth Systems' current ROCE % is -0.59%. Overall, SkinHealth Systems has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' ROCE % compare to SLSN and GROV?
SkinHealth Systems' ROCE % of -0.59% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.78, based on 1,938 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SkinHealth Systems's current ROCE % is -0.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.50, compared to a current price of $0.66 — trading 55.9% below its estimated fair value. The current ROCE % is -0.59%. SkinHealth Systems' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current ROCE % is -0.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SkinHealth Systems (SKIN) Overvalued in 2026?

Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued. The current stock price of $0.66 is trading 55.9% below its estimated GF Value™ of $1.50. GuruFocus considers SkinHealth Systems to be Possible Value Trap.

Key valuation signals for SKIN:

  • ROCE %: -0.59%
  • GF Value™: $1.50 vs. price of $0.66 (55.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SkinHealth Systems Business Description

Other Exchanges V7A0:Germany
Address 2165 Spring Street, Long Beach, CA, USA, 90806
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
49GF Score

Get the complete analysis for SKIN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.66
Price
$1.50
GF Value